Cristin-person-ID: 23159
Person

Olav Engebråten

  • Stilling:
    Førsteamanuensis
    ved Institutt for kreftforskning ved Universitetet i Oslo
  • Stilling:
    Overlege
    ved Avdeling for kreftbehandling ved Oslo universitetssykehus HF
  • Stilling:
    Overlege
    ved Avdeling for kreftbehandling ved Oslo universitetssykehus HF

Resultater Resultater

An integrated omics approach highlights how epigenetic events can explain and predict response to neoadjuvant chemotherapy and bevacizumab in breast cancer.

Fleischer, Thomas; Haugen, Mads; Ankill, Jørgen; Silwal-Pandit, Laxmi; Børresen-Dale, Anne-Lise; Hedenfalk, Ingrid; Hatschek, Thomas; Tost, Jörg; Engebråten, Olav; Kristensen, Vessela N.. 2024, Molecular Oncology. KAROLINSKA, UIO, OUS, GNC, KI, SVERIGEVitenskapelig artikkel

Association of the CHEK2 c.1100delC variant, radiotherapy, and systemic treatment with contralateral breast cancer risk and breast cancer-specific survival.

Morra, Anna; Schreurs, Maartje A. C.; Andrulis, Irene L.; Anton-Culver, Hoda; Augustinsson, Annelie; Beckmann, Matthias W.; Behrens, Sabine; Bojesen, Stig E.; Bolla, Manjeet K.; Brauch, Hiltrud mfl.. 2023, Cancer Medicine. MONASH, MAYO, UNIHEIDEL, MHH, DEHIERRO, HELMOLTZ, IFOM, USKIMVS, UHN, MAKEDONIA, HYKS, AHUS, UONCACH, HCLN, LUNENFELD, KUL, KYS, PAKISTAN, UzK, Lu, MELB, OUS, FOX, ET, TUOE, KCLUOL, UZLEUVEN, UKHE, NCI, UEF, UIO, DKFZ, VV, UIT, KAROLINSKA, CRO, OULU, SPANIA, GENTOFTE, UOSC, SÖS, UoM, HHU, NKIAVL, UoS, UoU, TYSKLAND, UoW, UKERLANGEN, NEDERLAND, KI, MAHSC, USA, SU, HELLAS, CUitCoNY, MSKCC, UOC, PUM, KU, VIB, IKP, ACS, CANCERVIC, PETERMAC, ICR, UCI, UHLARISSA, UOT, LUMCVitenskapelig artikkel

MRI Assessment of Changes in Tumor Vascularization during Neoadjuvant Anti-Angiogenic Treatment in Locally Advanced Breast Cancer Patients.

Mo, Torgeir; Brandal, Siri Helene Bertelsen; Geier, Oliver; Engebråten, Olav; Nilsen, Line; Kristensen, Vessela N.; Hole, Knut Håkon; Hompland, Tord; Fleischer, Thomas; Seierstad, Therese. 2023, Cancers. UIO, OUSVitenskapelig artikkel

Evaluation of European-based polygenic risk score for breast cancer in Ashkenazi Jewish women in Israel.

Levi, Hagai; Carmi, Shai; Rosset, Saharon; Yerushalmi, Rinat; Zick, Aviad; Yablonski-Peretz, Tamar; Wang, Qin; Bolla, Manjeet K.; Dennis, Joe; Michailidou, Kyriaki mfl.. 2023, Journal of Medical Genetics. UTA, MONASH, MAYO, ISRAEL, MHH, SYDNEY, BWH, UL, NIEHS, IFOM, EMC, UHN, MAKEDONIA, AHUS, HCLN, UONCACH, LUNENFELD, KUL, KYS, RUSSLAND, Lu, MELB, OUS, FOX, ET, BGU, UZLEUVEN, UKHE, OMR, NCI, UEF, UdSFIdN, UIO, TOSU, DKFZ, VU, BCCA, VV, KAROLINSKA, HHB, UP-SACLAY, CITYOFHOPE, SPANIA, GENTOFTE, MCGILL, UoK, SÖS, CIBERESP, UoM, KYPROS, NKIAVL, UBC, UoS, UoU, TYSKLAND, UKERLANGEN, UWA, KI, MAHSC, SU, USA, HSPH, HELLAS, CUitCoNY, MSKCC, UOC, PUM, KU, IARC, VIB, IKP, HMS, CS, CURTIN, ACS, TUMORI, CANCERVIC, ICR, UCI, UHLARISSA, UOT, LUMC, UCLVitenskapelig artikkel

Spectrum and Frequency of Germline FANCM Protein-Truncating Variants in 44,803 European Female Breast Cancer Cases.

Figlioli, Gisella; Billaud, Amandine; Wang, Qin; Bolla, Manjeet K.; Dennis, Joe; Lush, Michael; Kvist, Anders; Adank, Muriel A.; Ahearn, Thomas U.; Antonenkova, Natalia N. mfl.. 2023, Cancers. MONASH, MHH, UM, IFOM, UHN, LUNENFELD, KYS, UzK, PAKISTAN, RUSSLAND, STORBRITAN, MELB, OUS, ET, RB, TUOE, KCLUOL, IEO, UKHE, NCI, OMR, UEF, UIO, DKFZ, VV, KAROLINSKA, CRO, SPANIA, GENTOFTE, CNIO, SVERIGE, KYPROS, NKIAVL, UoU, TYSKLAND, NEDERLAND, UKERLANGEN, KI, USA, HELLAS, UOC, PUM, KU, IKP, CANCERVIC, IGR, UHLARISSA, UOT, LUMCVitenskapelig artikkel
1 - 5 av 130 | Neste | Siste »